Voluntary announcement - ind for subcutaneous infusion of bj007 for injection (sc) was approved by U.S. FDA

Jun 10, 2026 at 10:27 AM UTC · Issued by Shanghai Bao Pharmaceuticals Co Ltd Class H via HKEXnews

Shanghai Bao Pharmaceuticals Co Ltd Class H (2659) Press Release